Clinical trials
Phase 1/2 Alzheimer Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
93 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 4 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 3 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 8 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 10 |
| 2021 | 8 |
| 2022 | 7 |
| 2023 | 8 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 46 |
| Recruiting | 16 |
| Unknown status | 15 |
| Active, not recruiting | 5 |
| Terminated | 5 |
| Not yet recruiting | 3 |
| Withdrawn | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brigham and Women's Hospital | 3 |
| Massachusetts General Hospital | 3 |
| Oregon Health and Science University | 3 |
| AC Immune SA | 2 |
| Alzamend Neuro, Inc. | 2 |
| Annovis Bio Inc. | 2 |
| Cognition Therapeutics | 2 |
| Jeff Burns, MD | 2 |
| Medipost Co Ltd. | 2 |
| Seoul National University Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 93 |
| Dementia | 20 |
| Cognitive Dysfunction | 16 |
| Central Nervous System Diseases | 4 |
| Inflammation | 4 |
| Parkinson Disease | 4 |
| Brain Diseases | 3 |
| Neurodegenerative Diseases | 3 |
| Plaque, Amyloid | 3 |
| Amyotrophic Lateral Sclerosis | 2 |
Trials
Showing 26 to 50 of 93. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.